Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis-Reference-Cited by-同舟云学术

Association of Androgen Deprivation Therapy with Metabolic Disease in Prostate Cancer Patients: An Updated Meta-Analysis

Published:2022-12 Issue: Volume: Page:
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Swaby Justin,Aggarwal Ankita^ORCID,Batra Akshee^ORCID,Jain Anubhav,Seth Lakshya^ORCID,Stabellini Nickolas^ORCID,Bittencourt Marcio Sommer^ORCID,Leong Darryl,Klaassen Zachary,Barata Pedro^ORCID,Sayegh Nicolas^ORCID,Agarwal Neeraj^ORCID,Terris Martha,Guha Avirup

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference57 articles.

1. Common Cancer Sites - Cancer Stat Facts. SEER. Accessed July 8, 2022. https://seer.cancer.gov/statfacts/html/common.html.

2. Causes of death among patients with metastatic prostate cancer in the US from 2000 to 2016;Elmehrath;JAMA Netw Open,2021

3. What do prostate cancer patients die of?;Riihimäki;Oncologist,2011

4. The prevalence of cardiovascular disease and its risk factors among prostate cancer patients treated with and without androgen deprivation;Pinthus;JCO,2020

5. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer;Keating;J Clin Oncol,2006

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factores de riesgo cardiovascular en pacientes con cáncer de próstata de una unidad de cardio-oncología;Revista Ciencias Básicas en Salud;2024-05-16

2. From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer;Cancers;2024-04-18

3. Understanding Cardiovascular Risk in Prostate Cancer: Role of Disparities, Diabetes, and Aging;Current Treatment Options in Cardiovascular Medicine;2024-04-02

4. A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?;Critical Reviews in Oncology/Hematology;2024-04